Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) EBT Margin (2016 - 2024)

vTv Therapeutics' EBT Margin history spans 10 years, with the latest figure at 26100.0% for Q4 2024.

  • For Q4 2024, EBT Margin changed N/A year-over-year to 26100.0%; the TTM value through Sep 2025 reached 166935.29%, down 16467439.0%, while the annual FY2024 figure was 2222.71%, N/A changed from the prior year.
  • EBT Margin for Q4 2024 was 26100.0% at vTv Therapeutics, down from 591.9% in the prior quarter.
  • Across five years, EBT Margin topped out at 25.11% in Q4 2020 and bottomed at 105366.67% in Q4 2021.
  • The 4-year median for EBT Margin is 17722.22% (2021), against an average of 31446.3%.
  • The largest annual shift saw EBT Margin skyrocketed 9833940bps in 2020 before it crashed -10539178bps in 2021.
  • A 4-year view of EBT Margin shows it stood at 25.11% in 2020, then plummeted by -419665bps to 105366.67% in 2021, then soared by 36bps to 67666.67% in 2022, then surged by 61bps to 26100.0% in 2024.
  • Per Business Quant, the three most recent readings for VTVT's EBT Margin are 26100.0% (Q4 2024), 591.9% (Q1 2024), and 67666.67% (Q4 2022).